GH · NASDAQ · Medical - Diagnostics & Research

Guardant Health

Blood and tissue cancer tests spanning screening, monitoring, and treatment selection.

$161.50
After-hours close−0.05 (−0.03%)
At close$161.55(−4.14%)
DateEstimateReportedSurprise
Oct 2026−$0.28
Jul 2026−$0.76−$0.90−18.1%
May 2026−$0.47−$0.85−80.9%
Feb 2026−$0.77−$0.90−17.4%
Oct 2025−$0.48−$0.39+18.7%

The latest year is open to everyone — the 34 quarters behind it read with an account.

Sign in
Jul 2025
Apr 2025
Feb 2025
Nov 2024
Aug 2024
May 2024
Feb 2024
Nov 2023
Aug 2023
May 2023
Feb 2023
Nov 2022
Aug 2022
May 2022
Feb 2022
Nov 2021
Aug 2021
May 2021
Feb 2021
Nov 2020
Aug 2020
May 2020
Feb 2020
Nov 2019
Aug 2019
May 2019
Mar 2019
Nov 2018
Oct 2018
Mar 2018
Dec 2017
Sep 2017
Jun 2017
Mar 2017
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Oct 28, 2026−$0.28$350.1M
Jul 30, 2026−$0.76−$0.90−18.1%$314.2M$335.0M+6.6%
May 7, 2026−$0.47−$0.85−80.9%$279.2M$301.7M+8.1%
Feb 19, 2026−$0.77−$0.90−17.4%$272.4M$281.3M+3.2%
Oct 29, 2025−$0.48−$0.39+18.7%$267.6M$265.2M−0.9%

The latest year is open to everyone — the 34 quarters behind it read with an account.

Sign in
Jul 30, 2025
Apr 30, 2025
Feb 20, 2025
Nov 6, 2024
Aug 7, 2024
May 9, 2024
Feb 22, 2024
Nov 6, 2023
Aug 3, 2023
May 9, 2023
Feb 23, 2023
Nov 3, 2022
Aug 4, 2022
May 5, 2022
Feb 23, 2022
Nov 4, 2021
Aug 5, 2021
May 6, 2021
Feb 24, 2021
Nov 5, 2020
Aug 6, 2020
May 7, 2020
Feb 24, 2020
Nov 7, 2019
Aug 6, 2019
May 9, 2019
Mar 12, 2019
Nov 19, 2018
Oct 5, 2018
Mar 31, 2018
Dec 31, 2017
Sep 30, 2017
Jun 30, 2017
Mar 31, 2017